Health and Healthcare
5864 Articles
Drug overdose deaths for the 12 months ending January 2017 rose 21%, according to data from the CDC. Maryland led…
Cellectis shares tumbled early on Tuesday after the firm announced that a couple of its early-stage studies were put on…
BioCryst Pharmaceuticals saw its shares make a handy gain on early Tuesday after it released the final results from its…
Insmed saw its shares more than double early on Tuesday after the firm released late-stage results from its clinical study…
SteadyMed shares plummeted after the firm had a setback from the FDA regarding its pulmonary arterial hypertension treatment.
Taking more than a prescribed amount of medication leads to nearly 1.5 million calls annually to U.S. poison control centers.
ImmunoGen announced this week that it has decided to partner with Jazz Pharmaceuticals, and investors have pushed Immunogen shares to…
Mazor Robotics saw its shares make a handy gain to kick off hump day after it was announced that the…
Otonomy saw its shares crater after the firm announced results for its Averts-1 late-stage trial of Otividex in patients with…
ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.
Acorda Therapeutics saw its shares get crushed early on Tuesday after the firm received a Refusal to File letter from…
Gilead Sciences shares have been in a holding pattern for a while. Analysts have said that the firm needs to…
The August 15 short interest data have been compared with the previous report, and short interest moves in the selected…
The August 15 short interest data have been compared with the previous figures, and short interest in most of these…
Ultragenyx Pharmaceutical just hit a 52-week low and analysts have slashed and burned their price target expectations. This is after…
Our top personal finance-related articles today. Your wallet will thank you later.